Honghao Fang

Honghao Fang



M.Sc., global health science and epidemiology, University of Oxford; B.Sc., health, health care administration, and management, Fudan University

Summary of Experience

Ms. Fang is a health economist who specializes in generating evidence from health economics and outcomes research (HEOR). She conducts research to assess clinical, economic, and humanistic burdens of various diseases and to compare clinical effectiveness, safety, and economic values across different treatments. Ms. Fang has expertise in economic modeling, including cost-effectiveness and budget impact analysis, as well as conducting patient and physician surveys, chart reviews, real-world database analyses, and systematic literature reviews. She has worked across a variety of disease areas, including oncology, hematology, dermatology, immunology, infectious diseases, mental health disorders, and rare diseases. Ms. Fang’s research has supported assessments of market access and value propositions – including health technology assessment (HTA) submissions – in North America, Asia, the UK, and Europe. Her research has also been published in several peer-reviewed journals and presented at international conferences.